Literature DB >> 32105152

The reversed passive Arthus reaction as a model for investigating the mechanisms of inflammation-associated hemostasis.

Ophélie Le Chapelain1, Soumaya Jadoui1, Yacine Boulaftali1, Benoit Ho-Tin-Noé1.   

Abstract

In recent years, accumulating evidence has indicated that platelets continuously repair vascular damage at sites of inflammation and/or infection. Studies in mouse models of inflammation have highlighted the fact that the mechanisms underlying bleeding prevention by platelets in inflamed organs can substantially differ from those supporting primary hemostasis following tail tip transection or thrombus formation in models of thrombosis. As a consequence, exploration of the hemostatic function of platelets in inflammation, as well as assessment of the risk of inflammation-induced bleeding associated with a platelet deficit and/or the use of anti-thrombotic drugs, require the use of dedicated experimental models. In the present review, we present the pros and cons of the cutaneous reversed passive Arthus reaction, a model of inflammation which has been instrumental in studying how inflammation causes vascular injury and how platelets continuously intervene to repair it. The limitations and common issues encountered when working with mouse models of inflammation for investigating platelet functions in inflammation are also discussed.

Entities:  

Keywords:  Inflammation; platelets; reversed passive Arthus reaction; vascular integrity

Year:  2020        PMID: 32105152     DOI: 10.1080/09537104.2020.1732325

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  1 in total

1.  Research Priorities for Plasma and Platelet Transfusion Strategies in Critically Ill Children: From the Transfusion and Anemia EXpertise Initiative-Control/Avoidance of Bleeding.

Authors:  Marianne E Nellis; Kenneth E Remy; Jacques Lacroix; Jill M Cholette; Melania M Bembea; Robert T Russell; Marie E Steiner; Susan M Goobie; Adam M Vogel; Gemma Crighton; Stacey L Valentine; Meghan Delaney; Robert I Parker
Journal:  Pediatr Crit Care Med       Date:  2022-01-01       Impact factor: 3.971

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.